Manipal Health Enterprises shares fell sharply on Thursday day after their strong market debut, triggering profit booking. Analysts remain constructive on the company's long-term prospects but advise fresh investors to wait for better entry levels, citing premium valuations, while allotted investors can continue holding with a stop-loss at Rs 620.

Manipal Health Enterprises is set to list its Rs 9,275.22 crore mainboard IPO on the BSE and NSE on August 5. With grey market trends indicating a mild discount of Rs 5 to Rs 6…

Temasek-backed Manipal Health shares surged after its $973 million IPO, reflecting strong investor confidence in India's growing healthcare and hospital sector.

The company's IPO is currently commanding a grey market premium (GMP) of around Rs 3, or nearly 1% over the upper price band of Rs 590 per share, indicating an estimated listing…

Manipal Health Enterprises debuts at ₹655, 11% above IPO price, amid strong demand and significant investor interest.